Objective-The thromboxane receptor (TPr) and multiple TPr ligands, including thromboxane A 2 (TxA 2 ) and prostaglandin H 2 , are elevated during vascular and atherothrombotic diseases. How TPr stimulation causes vascular injury remains poorly defined. This study was conducted to investigate the mechanism by which TPr stimulation leads to vascular injury.
I ncreased formation of reactive oxygen species (ROS)/ reactive nitrogen species is associated with several cardiovascular disease states. [1] [2] [3] Multiple oxidase systems contribute to increased levels of ROS/reactive nitrogen species, notably NAD(P)H oxidase. 2, 4, 5 Endothelial nitric oxide synthase (eNOS) itself can generate superoxide anions (O 2 ⅐Ϫ ) rather than nitric oxide (NO), a phenomenon known as eNOS "uncoupling." 6 This transformation of eNOS from a protective enzyme to a contributor of oxidative stress has been observed in an in vitro model, 7 in animal models of cardiovascular diseases, 8 -10 and in patients with cardiovascular risk factors. 11, 12 eNOS uncoupling, which is associated with diseases such as diabetes, hypertension, and atherosclerosis, has been ascribed to several mechanisms, including inadequate concentrations of L-arginine and tetrahydrobiopterins (BH4), as well as disruption of the zinc-thiolate center of eNOS. [7] [8] [9] [10] [11] [12] Eicosanoids, derived from arachidonic acid, are present in a wide variety of human tissues and participate in diverse processes, including inflammation and immunity, hemostasis, wound healing, kidney function, and vessel tone. 13 The biosynthesis of eicosanoids involves the formation of thromboxane A 2 (TxA 2 ), prostacyclin (PGI 2 ), and prostaglandins. Eicosanoid biosynthetic pathways require 2 cyclooxygenase isoforms (cyclooxygenase 1 and 2), to catalyze the conversion of arachidonic acid to prostaglandin H 2 , the central metabolite in the pathway. Most tissues express one or both cyclooxygenase enzymes and produce a variety of eicosanoids. 14, 15 Several endogenously produced eicosanoids, such as prostaglandin H 2 , TxA 2 , HETEs, and isoprostanes, exert their physiological effects by binding to the thromboxane receptor (TPr). TPr is a 7-membrane-spanning, G-protein-coupled receptor that on activation initiates many processes important in the pathophysiology of multiple diseases and their sequelae. 13 For example, TPr stimulation activates human monocytes and facilitates tumor necrosis factor-␣ and interleukin-1␤ production. 16 The prothrombotic properties of TPr result from its promotion of platelet activation, aggregation, and degranulation. TxA 2 is a potent stimulus for neointima formation in coronary arteries and promotes smooth muscle cell proliferation and migration. 15, 16 TPr expression and serum levels of multiple TPr ligands are elevated, both locally and systemically, in patients in several vascular and thrombotic diseases. 15 TPr density is increased in atherosclerotic coronary arteries and in vessels with severe intimal hyperplasia. 15, 17 These observations point to TPr as a potential target for therapeutic interventions and the development of novel selective antagonists for the treatment of human cardiovascular disease. TPr blockade prevents the formation of occlusive thrombi in models of myocardial infarction. 18 Indeed, TPr blockers and TxA 2 synthase inhibitors attenuate ischemia/reperfusion-mediated injury in several organs, including the liver 19 and heart. 20 In addition, pharmacological inhibition or genetic deletion of TPr blocks the development of atherosclerosis in nondiabetic apolipoprotein E knockout mice, indicating that TPr is important for the initiation and progression of atherosclerosis. 21, 22 Recently, activation of TPr by TxA 2 has been found to promote O 2 ⅐Ϫ formation in vascular smooth muscle cells. [23] [24] [25] However, the mechanism by which TPr activation generates oxidant stress in endothelial cells is unknown. This study was conducted to determine whether TPr stimulation induces oxidative stress in endothelial cells and to investigate the mechanism underlying TPr-induced vascular injury. Our data reveal that TPr stimulation increases endothelial production of O 2 ⅐Ϫ and peroxynitrite (ONOO Ϫ ) by increasing protein kinase C-(PKC-)-dependent activation of NAD(P)H oxidase. Moreover, they suggest that these NAD(P)H oxidasederived ROS induce endothelial dysfunction by uncoupling of eNOS activity and increasing tyrosine nitration of the eicosanoid biosynthetic enzyme PGI 2 synthase (PGIS).
Materials and Methods
A full description of materials and methods, including cell culture, animals, localization and quantification of O 2 ⅐Ϫ in isolated aortae, preparation of membrane fractions, assay of cyclic GMP, cell viability, and cell apoptosis assays can be found in the supplemental materials, available online at http://atvb.ahajournals.org.
Quantification of O 2 ⅐؊ in Cultured Endothelial Cells
Dihydroethidium (DHE) is a cell-permeable dye that reacts with superoxide anions specifically to produce a hydroxylated product, 2-hydroxy-ethidium (HE-OOH), which spontaneously losses water to produce the fluorescent derivative HO-Et ϩ . 26 Cultured bovine aortic endothelial cells (BAEC) were incubated with DHE (5 mol/L) for 30 minutes at 37°C, followed by methanol extraction. High-performance liquid chromatography (HPLC) was applied to separate and quantify oxyethidium (a product of DHE and O 2 ⅐Ϫ ) and ethidium (a product of DHE auto-oxidation) by column C-18. 27 The DHE staining images were analyzed by measuring fluorescent mean intensity using Bioquant image analysis software (Nashville, Tenn).
HPLC Detection of O 2 ⅐؊ in Isolated Aortae
Superoxide anions were detected by using HPLC detection of oxyethidium in aortic sections, as described previously. 27
Measurement of ONOO ؊ Production in Cultured Endothelial Cells
ONOO Ϫ formation was determined by ONOO Ϫ -dependent oxidation of dihydrorhodamine 123 (DHR 123) to rhodamine 123, as described previously. 28 Briefly, confluent BAEC were treated with IBOP (1 mol/L) for 4 hours with or without a 30-minute pretreatment with SQ29548. The cells were rinsed with medium and then incubated with DHR 123 (5 mol/L) for 60 minutes at 37°C. Rhodamine 123 fluorescence was measured at an excitation wavelength of 485 nm and an emission wavelength of 545 nm using a Synergy HT Multi-Detection Microplate Reader. Results are expressed as a percentage of oxidation in untreated control cultures.
Measurement of NO Production in Endothelial Cells
NO levels were determined using the NO-specific fluorescent dye DAF-2 DA, as described previously. 29 Briefly, BAEC were serumstarved overnight in phenol red-free endothelial cell basal medium (EBM) medium and then incubated in IBOP (1 mol/L) or U46619 (1 mol/L) for 24 hours. The cells were then loaded with DAF-2 DA (5 mol/L) for 30 minutes, washed with PBS to remove excess probe, and incubated with 10 mol/L A23187 and 100 mol/L CaCl 2 in the dark at 37°C for 15 minutes. The cells were washed twice with PBS, and DAF-2T fluorescence was measured at a 485-nm excitation wavelength and a 545-nm emission wavelength using a spectrofluorometer (Synergy HT).
Measurement of PGI2, eNOS Activity, eNOS Dimers/Monomers, and BH4
The formation of PGI2 was assayed by monitoring 6-keto-PGF1-␣, the stable PGI2 metabolite, in cell culture media after IBOP (1 mmol/L) treatment for 24 hours in BAEC using a specific enzyme immunoassay (EIA) kit (Cayman Chemical). To measure eNOS activity, we monitored conversion of 3 H-L-arginine into 3 H-Lcitrulline, as described previously. 30 Levels of eNOS dimers and monomers were determined using low-temperature SDS-PAGE, as detailed previously. 30 Intracellular BH4 levels were assayed using HPLC, as previously described. 27
Immunoprecipitation and Western Blotting
Immunoprecipitation and Western blotting were performed as described previously. 30
Statistical Analyses
Values are expressed as meanϮSEM. Statistical comparisons were performed using a Student t test or 1-way ANOVA with the Bonferroni procedure for post hoc analysis. Values of PϽ0.05 were considered significant.
Results

TxA 2 Mimetics Reduce eNOS Activity in a TPr-Dependent Manner
Cellular redox status is a key aspect of endothelial biology. Endothelial redox state influences NO production, an essential factor for endothelial function, by altering eNOS activity. To determine whether TPr stimulation alters eNOS activity, we exposed confluent BAEC to varying concentrations of IBOP (1 mol/L), a potent TxA 2 mimetic, for 24 hours. IBOP inhibited insulin-stimulated or vascular endothelial growth factor-stimulated eNOS activity ( Figure 1A ). Exposure of BAEC to U46619 (1 mol/L), a TPr agonist structurally related to IBOP, caused a similar reduction of eNOS activity ( Figure 1B) . IBOP-or U46619-induced reduction in eNOS activity was partially blocked by pretreatment of BAEC with SQ29548 (10 mol/L), a potent TPr antagonist ( Figure 1A and 1B).
TxA 2 Mimetics Suppress NO Release and Bioactivity
Next, we investigated whether the diminished eNOS activity associated with TPr activation was accompanied by a decrease in NO release. Analysis of NO release using the fluorescent dye DAF-2DA revealed that exposure of BAEC to IBOP signifi-cantly reduced NO release ( Figure 1C ). Importantly, the addition of tempol and apocynin, 2 potent antioxidants, attenuated the inhibitory effects of IBOP on NO release ( Figure 1C ), suggesting a reduction of NO by O 2
⅐Ϫ
. NO exerts its biological effects primarily through activation of guanylyl cyclase, which generates cGMP. Thus, intracellular levels of cGMP are an index of NO bioactivity. As depicted in Figure 1D , cGMP levels were significantly lower in BAEC exposed to IBOP than in cells treated with vehicle. It is of note that the addition of polyethyl glycated superoxide dismutase reduced the effects of IBOP on cGMP ( Figure 1D ), supporting that reduction of NO bioactivity by IBOP.
TxA 2 Mimetic Increases O 2 ⅐؊ Production
NO bioactivity is determined mainly by the rate of NO production or the rate of NO inactivation by ROS such as O 2
⅐Ϫ
. Recent studies suggest that TPr promotes O 2 ⅐Ϫ formation in vascular smooth muscle cells. [23] [24] [25] Therefore, we investigated whether TPr alters NO bioactivity by increasing O 2 ⅐Ϫ in endothelial cells. As shown in Figure 2A , treatment of BAEC with IBOP (1 mol/L) significantly increased O 2 ⅐Ϫ release. To determine whether TPr is required for IBOP-induced O 2 ⅐Ϫ production, BAEC were pretreated with SQ29548, a selective TPr antagonist. As shown in Figure 2A 
⅐Ϫ was also quenched by pretreatment with tempol, a potent antioxidant (Figure 2A ).
To exclude potential off-target effects of SQ29548, TPr expression was genetically suppressed by the transfection of TPr-specific small interfering RNA (siRNA). Western blot analysis confirmed that TPr levels were reduced in BAEC transfected with TPr-specific siRNA but not in control siRNA-transfected cells ( Figure 2B ). As shown in Figure 2C , transfection of neither TPr-specific siRNA nor control siRNA altered the basal levels of O 2 ⅐Ϫ in BAEC. As expected, IBOP significantly increased O 2 ⅐Ϫ release in BAEC transfected with control siRNA, which was inhibited by the addition of tempol (10 mol/L) ( Figure 2C ). Conversely, transfection of TPrspecific siRNA ablated IBOP-induced O 2 ⅐Ϫ ( Figure 2C ).
TxA 2 Mimetic IBOP Increases ONOO ؊ Formation
O 2 ⅐Ϫ rapidly reacts with NO to form ONOO Ϫ , a powerful oxidant. At physiological pH, ONOO Ϫ has a half-life less than 1 second and stably modifies proteins with 3-nitrotyrosine (3-NT), a modification that is considered to be a footprint for reactive nitrogen species, including ONOO Ϫ , in cultured endothelial cells. 31 We found that a 24-hour exposure of BAEC to IBOP increased 3-NT-positive proteins ( Figure 3A ), implying that TPr activation increased ONOO Ϫ formation in BAEC. In line with this result, IBOP also significantly enhanced ONOO Ϫdependent oxidation of DHR 123 in BAEC ( Figure 3B ). Importantly, preadministration of SQ29548 abolished IBOP-induced DHR 123 oxidation, suggesting that TPr is required for IBOPinduced ONOO Ϫ formation. Furthermore, blocking the sources of ONOO Ϫ formation by pretreatment with either tempol (scavenging O 2 ⅐Ϫ ) or L-NAME (a nonselective inhibitor for nitric oxide synthase), also inhibited DHR 123 oxidation ( Figure 3B ).
The TxA 2 Mimetic IBOP Increases PGIS Nitration and Decreases PGI 2 Formation
To determine whether TPr-derived ROS may have detrimental effects other than NO inactivation, we analyzed PGIS nitration and PGI 2 formation in IBOP-exposed BAEC. We have previously demonstrated that ONOO Ϫ inactivates PGIS by increasing tyrosine nitration at its active site. 32, 33 In addition, PGIS nitration triggers TPr-mediated vasospasms in vessels exposed to hypoxia or endotoxins. Western blot A and B, Effects of IBOP and U46619 on the conversion of 3 H-L-arginine into 3 H-citruline in BAEC. Confluent BAEC were incubated with the indicated concentrations of IBOP or U46619 for 24 hours. After the incubation, cells were stimulated with either insulin (100 nmol/L) or vascular endothelial growth factor (VEGF) (50 ng/mL) for 10 minutes. A subset of cultures was preincubated with the TPr antagonist SQ29548 (10 mol/L); ࡔPϽ0.05, IBOP or U46619 versus control; †PϽ0.01, IBOP or U46619 plus SQ29548 versus IBOP alone (nϭ6). C, Effects of antioxidants on NO production in BAEC. BAEC were treated with IBOP (1 mol/L) for 24 hours with or without a 30-minute pretreatment with tempol (10 mol/L) or apocynin (100 mol/L). NO was assayed by using the fluorescent dye DAF-1 DA. ࡔPϽ0.05, IBOP versus control. NS indicates no statistical difference (nϭ4). D, Effects of IBOP on NO bioavailability in human umbilical vein endothelial cells. Human umbilical vein endothelial cells were treated with IBOP (1 mol/L) for 24 hours, with or without a 30-minute pretreatment with polyethyl glycated superoxide dismutase (PEG-SOD) (10 U/mL) or apocynin (100 mol/L). Intracellular cGMP contents were assayed as described in Materials and Methods. ࡔPϽ0.05 versus control. NS indicates no statistical difference (nϭ4).
analysis of 3-NT immunoprecipitates using an anti-PGIS antibody or PGIS immunoprecipitates using anti-3-NT antibody revealed that a 24-hour exposure of BAEC to IBOP significantly increased the amount of nitrated PGIS ( Figure 3C and Supplemental Figure II) . IBOP also significantly suppressed the levels of 6-keto-PGF1␣, a stable hydrolyzed metabolite of PGI 2 ( Figure 3D ). As cyclooxygenase is the rate-limiting enzyme for PGI 2 formation, a small reduction of PGIS activity might be due to increased availability of its substrate, cyclooxygenase-derived prostaglandin H 2 , to active PGIS.
TPr Activation Uncouples eNOS
All 3 NOS are dimeric enzymes comprised of 2 identical subunits with a zinc tetrathiolate (ZnS 4 ) cluster. The zinc-thiolate structure is essential in maintaining both eNOS dimer structure and activity. 34 We had previously shown that ONOO Ϫ , formed by O 2 ⅐Ϫ and NO at a diffusion-controlled rate, oxidizes the zinc-thiolate cluster of eNOS and uncouples the enzyme (causing it to form O 2 ⅐Ϫ instead of NO). 32 Thus, we investigated whether increased ONOO Ϫ formation associated with TPr activation increases levels of inactive eNOS monomers in BAEC. Low-temperature SDS-PAGE revealed that exposure of BAEC to IBOP (1 mol/L) for 24 hours significantly increased eNOS monomers, and adenoviral overexpression of the dominant negative mutant of either p47 phox or p67 phox , 2 essential components of active NAD(P)H oxidase, inhibited IBOP-induced reduction of eNOS dimers and the increase of eNOS monomers ( Figure  4A ). Consistent with this result, pretreatment with antioxidants (apocynin, tempol, or polyethyl glycated superoxide dismutase) all lowered IBOP-induced NO reduction ( Figure  1C ) and cGMP reduction ( Figure 1D ). We also found that a 24-hour exposure of BAEC to either IBOP or U46619 significantly decreased levels of BH4 ( Figure 4B ), a cofactor that is essential for eNOS activity, which was prevented by the addition of apocynin ( Figure 4B ). Similarly, adenoviral overexpression of p67 phox dominant negative, which selectively inhibited NAD(P)H oxidase, also reversed TPr-induced BH4 reduction ( Figure 4C ).
PKC-Is Required for TPr-Mediated Activation of NAD(P)H Oxidase
PKC-is an atypical PKC that is found in many vascular cell types, including BAEC. We have previously found that PKC-is required for hypochlorite (HOCl)-induced activation of NADP(H) oxidase in endothelial cells. 27 This led us to investigate whether PKC-is also required for TPr-mediated increases in O 2 ⅐Ϫ and ONOO Ϫ in BAEC. Exposure of BAEC to U46619 significantly increased the amount of PKC-in membrane fractions, an index of PKC-activation ( Figure  5A ). Pharmacological inhibition of PKCwith PKC-specific myristoylated pseudosubstrate (PKC--PS) abolished U46619-induced translocation of PKC-from cytosol to membrane fractions ( Figure 5A) . Similarly, exposure of BAEC to IBOP increased the phosphorylation of PKC-at Thr410 ( Figure 5B ).
Next, we investigated the role of PKC-in NAD(P)H oxidase activation. NAD(P)H oxidase activation requires the translocation of p67 phox from the cytoplasm to the cell membrane. Western blot analysis of membrane fractions revealed that IBOP or U46619 markedly increased membrane locations of p67 phox ( Figure 5C ). Notably, the increase of membrane p67 phox was markedly attenuated by the addition of PKC-pseuosubstrate (PKC--PS), a selective PKCinhibitor ( Figure 5C ).
To exclude potential off-target effect of PKC--PS, we further tested whether genetic inhibition of PKC-affected the effects of TPr in endothelial cells. As depicted in Figure 5D , transfection of PKC-siRNA but not control siRNA markedly lowered the levels of PKC-in BAEC. Moreover, like TPr-specific siRNA, PKC--specific siRNA significantly reduced IBOP-induced O 2 ⅐Ϫ formation ( Figure 5E ). Finally, adenoviral overexpression of PKC-dominant negative but not adenoviruses encoding ⅐Ϫ production. Confluent BAEC were exposed to IBOP (1 mol/L) for 24 hours with or without a 30-minute pretreatment with SQ 29548 (1 mol/L) or tempol (10 mol/L). Cells were incubated with DHE the final 30 minutes of treatment, and intensity of DHE fluorescence was measured as described in Materials and Methods. ࡔPϽ0.05, IBOP-treated group versus control; †PϽ0.05 versus IBOP-treated group (nϭ4). B, Western blot analysis of TPr expression in BAEC transfected with TPrspecific siRNA or scrambled siRNA (Con siRNA) for 48 hours. ࡔPϽ0.01, Tpr-siRNA versus control siRNA (nϭ4). C, TPrdependent O 2 ⅐Ϫ production. BAEC were transfected with control siRNA or TPr-specific siRNA for 24 hours. After the transfection, BAEC were treated with IBOP (1 mol/L) for 24 hours in the presence or absence of tempol (10 mol/L). O 2 ⅐Ϫ was determined by DHE as described in Materials and Methods. ࡔPϽ0.05, control siRNA with IBOP versus control siRNA alone;
†PϽ0.05, IBOP-treated TPr-specific siRNA-transfected cells versus IBOP-treated control siRNA-transfected cells (nϭ4).
green fluorescent protein (GFP) blocked IBOP-increased formation of eNOS monomer ( Figure 5F ).
IBOP Increases O 2
⅐؊
, ONOO ؊ , and eNOS Monomers in Isolated Aortae
We next determined whether TPr activation increases O 2 ⅐Ϫ in isolated aortae ex vivo. Mouse aortae isolated from C57BL/6J mice were exposed to IBOP for 30 minutes, and O 2 ⅐Ϫ production was assayed by 2 independent methods. Consistent with the findings in cultured BAEC, exposure of mouse aortae to IBOP for 30 minutes significantly increased O 2 ⅐Ϫ production, as measured by both fluorescence imaging and HPLC ( Figure 6A and 6B) . Coadministration of L-NAME, a noncompetitive NOS inhibitor, markedly attenuated IBOPinduced O 2 ⅐Ϫ formation ( Figure 6C ), suggesting that uncoupled NOS contributes to O 2 ⅐Ϫ production.
NAD(P)H Oxidase Is Required for IBOP Induced O 2
⅐؊
, ONOO ؊ , and eNOS Monomers in Isolated Aortae
To further confirm that IBOP increased O 2 ⅐Ϫ production is through NAD(P)H oxidase activation, aortae isolated from (nϭ4) . B, Increased ONOO Ϫ formation. BAEC were exposed to IBOP (1 mol/L) for 4 hours with or without a 30-minute pretreatment with SQ29548 (4 mol/L), tempol (10 mol/L), or L-NAME (100 mol/L). ONOO Ϫ was measured by using DHR 123 oxidation as described in Materials and Methods. ࡔPϽ0.05, IBOP versus control; NS indicates no statistical difference (nϭ4). C, immunoprecipitation (IP)/Western blot (WB) analysis of PGIS nitration in BAEC treated with IBOP (0.1 to 1 mol/L) for 24 hours. ࡔPϽ0.05 versus control (nϭ3). D, Effects of IBOP on PGI 2 formation. BAEC were treated with IBOP (1 mol/L) for 24 hours, and PGIS activity was assayed by measuring the level of stable PGI 2 metabolite 6-keto-PGF1-␣ in cell culture supernatants. Data are expressed as meanϮSEM. ࡔPϽ0.05, IBOP versus control (nϭ5).
Figure 4. Identification of NAD(P)H oxidase as the source of O 2
⅐Ϫ resulting in eNOS uncoupling. A, Effects of NAD(P)H oxidase inhibition on IBOP-induced eNOS oxidation. BAEC were exposed to IBOP (1 mol/L) for 24 hours after being infected with adenoviruses encoding GFP (ad-GFP), the dominant negative mutants of p47 phox (ad-p47 phox DN), or the dominant negative mutants of p67 phox (ad-p67 phox DN). eNOS monomers and eNOS dimers were assayed as described in Methods and Materials. ࡔPϽ0.05, IBOP-treated GFP-infected cells versus untreated cells GFP alone;
†PϽ0.05, IBOP-treated cells versus untreated cells after ad-GFP transfection (monomer) (nϭ3). B, Effects of IBOP and U46619 on BH4 levels in BAEC. BAEC were treated with IBOP (1 mol/L) or U46619 (1 mol/L) for 24 hours in the presence or absence of 100 mol/L apocynin. BH4 was assayed as described in Materials and Methods (nϭ3). ࡔPϽ0.05, IBOP or U46619 versus untreated cells. NS indicates no statistical difference. C, Effects of NAD(P)H oxidase inhibition on the levels of BH4 and BH2ϩother biopterins levels in BAEC. Confluent BAEC were treated with IBOP (1 mol/L) for 24 hours after ad-GFP or ad-p67 phox DN transfection. ࡔPϽ0.05 versus untreated GFP-transfected cells; NS indicates no statistical difference (nϭ3). gp91 phox knockout mice were used. As shown in Figure 6A and 6B, IBOP treatment for 30 minutes increased O 2 ⅐Ϫ production in aortae of wild-type (WT) mice but not gp91 phox knockout mice. IBOP also increased ONOO Ϫ formation in WT aortae by immunohistochemical stain for 3-NT positive proteins, whereas IBOP did not increase 3-NT staining in gp91 phox knockout mice aortae ( Figure 6D ). Finally, exposure of mouse aortae to IBOP increased monomer of eNOS in WT but not in gp91 phox knockout mice ( Figure 6E ).
IBOP Increases Endothelial Cell Apoptosis and Decreases Cell Viability
There is abundant evidence that ROS contribute to vascular dysfunction through oxidative damage by impairing endothelial cell growth and causing apoptosis. Therefore, we next determined whether TPr activation affects endothelial cell viability and induces apoptosis. Exposure of BAEC to IBOP for 24 hours significantly decreased cell viability (Supplemental Figure IA ) and increased apoptosis (Supplemental Figure IB) , which was blocked by TPr antagonist SQ29548.
Discussion
In this study, we have provided evidence that TPr stimulation increases the production of ROS by increasing PKC-dependent NAD(P)H oxidase activation and that constant TPr stimulation causes endothelial dysfunction by uncoupling eNOS activity and increasing tyrosine nitration of PGIS, all of which result in excessive endothelial cell apoptosis.
One of the most important findings of the present study is that TPr stimulation via ONOO Ϫ leads to eNOS uncoupling.
Recent studies reveal that eNOS uncoupling might play a causal role in cardiovascular diseases, including hypertension, diabetes, and ischemic diseases. In this study, we further advance this concept by demonstrating that eNOS uncoupling arises from TPr stimulation. TPr stimulation not only decreased eNOS activity by increasing inactive eNOS monomers and reducing BH4 levels, but it also decreased NO bioavailability (as measured by cGMP). Notably, L-NAME was less effective than apocynin in suppressing TPr-initiated O 2 ⅐Ϫ formation in isolated aortae. Further evidence for a NAD(P)H oxidase-mediated eNOS uncoupling comes from the study with gp91 phoxϪ/Ϫ mice. IBOP treatment for 30 minutes increased O 2 ⅐Ϫ and ONOO Ϫ (3-NT staining) in the aortae of WT mice but not in those of gp91 phox knockout mice. Consistently, exposure of mouse aortae to IBOP increased monomer of eNOS in WT mice but not in gp91 phox knockout mice. Taken together, our data suggest that O 2 ⅐Ϫ and ONOO Ϫ derived from TPr-activated NAD(P)H oxidase function as "kindling" oxidants, acting to uncouple eNOS in endothelial cells.
Our earlier studies 33, 35 have demonstrated that submicromolar levels of ONOO Ϫ inhibit PGIS through PGIS nitration and, as a consequence, trigger TPr-mediated vasospasm and endothelial apoptosis. Here, we show that TPr in turn increases PGIS nitration. As we have shown that endogenous ONOO Ϫ induces PGIS nitration and TxA 2 activation in several disease conditions (eg, in atherosclerotic vessels, hypoxia-reperfusion injury, diabetes, and hypertension), 35 the ONOO Ϫ -PGIS nitration-TPr activation-ONOO Ϫ pathway might form a feed-forward loop to increase vascular injury ⅐Ϫ production is PKC--and TPr-dependent. BAEC were transfected with scrambled siRNA (control siRNA), PKC--specific siRNA, or TPr-specific siRNA. Transfected cells were labeled with 10 mol/L DHE and then treated with 1 mol/L IBOP for 30 minutes (nϭ5). O 2 ⅐Ϫ were detected as described in Materials and Methods. ࡔPϽ0.05, control siRNA treated with IBOP versus untreated control siRNA-transfected cells; †PϽ0.05, TPr siRNA plus IBOP or PKC-siRNA plus IBOP versus control siRNA plus IBOP. F, Western blot analysis of eNOS dimers and monomers in BAEC exposed to IBOP (1 mol/L) for 24 hours after transfection with adenoviruses encoding GFP or PKC-dominant negative (DN). The blot is a representative of 3 individual experiments. and endothelial dysfunction via eNOS uncoupling. This potential pathway is important, as TPr expression and serum levels of multiple TPr ligands are elevated, both locally and systemically, in patients undergoing angioplasty and in patients with several vascular and thrombotic conditions, including ischemia, unstable angina, myocardial infarction, and reocclusion after coronary thrombolysis. [15] [16] [17] Increased formation of 3-NT, a marker of ONOO Ϫ , has been detected in many diseases. 33, 35, 36 Because there is overwhelming evidence that ROS play a causal role in the development of cardiovascular diseases and diabetes, TPr-initiated ROS production might contribute to excessive oxidant stress observed in these diseases, and ROS formation might serve as the common pathway for TPr-induced vascular pathways. This observation might also be applicable to other cell types. Our recent report shows that the TxA 2 analogs IBOP and U46619 promote the formation of O 2 ⅐Ϫ in vascular smooth muscle cells. 25 PKC-is required for TPr-initiated O 2 ⅐Ϫ release and NAD(P)H oxidase activation in endothelial cells. Indeed, we have previously shown that HOCl increases O 2 ⅐Ϫ and ONOO Ϫ generation via PKC--dependent activation of NAD(P)H oxidase. 30 Activation of PKC-has also been shown to modulate TPr-mediated apoptosis in cardiac myocytes. 37 How TPr stimulation leads to PKC-activation remains unknown and warrants further investigation.
In summary, the data presented here reveal that TPr stimulation is a potent instigator of vascular endothelial dysfunction by its ability to enhance NAD(P)H oxidase assembly and translocation to the plasma membrane of the endothelial cell, probably via activation of PKC-. NAD(P)H oxidase-generated O 2 ⅐Ϫ and ONOO Ϫ , in turn, function as kindling oxidants, resulting in eNOS uncoupling, PGIS nitration, and endothelial dysfunction. Our results likely have broad implications in a variety of vascular diseases, including atherosclerosis, diabetes, hypertension, and ischemic injury. ⅐Ϫ production in isolated mouse aortae from WT or gp91 phox knockout mice. Aortae isolated from WT or gp91 phox knockout mice were treated with IBOP (1 mol/L) for 30 minutes. O 2 ⅐Ϫ was detected by using DHE fluorescence (10 mol/L DHE). ࡔPϽ0.01 versus untreated WT aortic ring; †PϽ0.05 versus WT IBOPtreated aortic ring (nϭ4). B, HPLC analysis of DHE-derived products in WT and gp91 phox knockout mice aortas exposed to IBOP (1 mol/L) for 30 minutes. Aortae were labeled with 10 mol/L DHE and homogenized for analysis of O 2 ⅐Ϫ . ࡔPϽ0.05 versus untreated WT aortic rings; †PϽ0.05 versus IBOP-treated WT aortic rings (nϭ4). C, DHE Fluorescence (10 mol/L DHE) in murine aortas treated with IBOP (1 mol/L) for 30 minutes in the presence or absence of apocynin (100 mol/L) or L-NAME (1 mmol/L) in fresh Krebs buffer. ࡔPϽ0.01 versus untreated aortic ring;
†PϽ0.05 versus IBOP-treated aortic ring (nϭ7 per group). D, Effects of IBOP on 3-NT immunofluorescence. Isolated aortae from WT and gp91 phox knockout mice were exposed to IBOP (1 mol/L) for 30 minutes, and 3-NT staining was assayed as described in Materials and Methods. ࡔPϽ0.05 versus untreated WT aortic rings; †PϽ0.05 versus IBOPtreated WT aortic rings (nϭ4). E, Effects of IBOP on the eNOS dimers and eNOS monomers in isolated aortae. Mouse aortae from WT or gp91 phox knockout mice were exposed to IBOP (1 mol/L) for 30 minutes. eNOS dimers and monomers were assayed as described in Materials and Methods. ࡔPϽ0.05, IBOP-treated WT aortic rings versus untreated WT aortic rings (nϭ4).
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